Division of Hematology and Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey/Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
Division of Geriatric Medicine, Clinic Barmelweid, Barmelweid, Switzerland.
Ann Palliat Med. 2023 Nov;12(6):1198-1214. doi: 10.21037/apm-23-433. Epub 2023 Oct 19.
Pain is the most prevalent symptom in cancer patients. To improve pain care, World Health Organization (WHO) Pain ladder was introduced in 1986 as a template for choosing pain medications in oncological settings. Since then, advancements in oncological treatments have improved the survival of cancer patients, requiring prolonged analgesia in various treatment stages. Additionally, there have been newer challenges in pain management with opioid epidemic and associated opioid use disorders. This has shifted the focus from WHO Pain Ladder and brought new importance to the rapidly evolving realm of interventional pain modalities for cancer pain management. This article reviews such interventional pain and minimally invasive neurosurgical options for pain management in cancer patients.
Systemic literature search in PubMed, Cochrane, and Embase. This included review articles, randomized controlled trials, non-randomized clinical trials (RCTs), and case series.
A large array of interventional pain modalities are available for oncological pain management. These modalities carry relatively lower risk and provide effective analgesia while reducing concerns related to opioid use disorder. They target various areas in the anatomical and physiological pain pathways and provide more focused options for pain management at various stages of cancer and survivorship. Additionally, with improved sterile techniques, better imaging modalities, and growing technical and clinical expertise, interventional pain modalities offer a safe and often more efficacious method of pain management nowadays. Procedural modalities like intrathecal (IT) pumps, neuromodulation, kyphoplasty, and newer more targeted ablative techniques are now increasingly finding more roles and indications in cancer population.
Interventional pain techniques are rapidly evolving and have become an integral part of cancer pain management. They can provide an additional option for cancer pain management, and can help reduce opioid consumption, and associated opioid side effects. With improvement in imaging modalities, procedural techniques, hardware, and infection control, they have a good safety profile and provide a rapid and efficacious approach for cancer pain management. This review articles aims to provide a basic understanding of various interventional pain modalities, their indications, efficacy, safety data, and associated complications.
疼痛是癌症患者最常见的症状。为了改善疼痛护理,世界卫生组织(WHO)于 1986 年引入了疼痛阶梯,作为在肿瘤学环境中选择疼痛药物的模板。自那时以来,肿瘤学治疗的进步提高了癌症患者的生存率,需要在各种治疗阶段延长镇痛。此外,阿片类药物流行和相关阿片类药物使用障碍带来了新的疼痛管理挑战。这使得人们的注意力从世界卫生组织疼痛阶梯转移,并为癌症疼痛管理的介入性疼痛模式的快速发展领域带来了新的重要性。本文综述了癌症患者疼痛管理中此类介入性疼痛和微创神经外科选择。
在 PubMed、Cochrane 和 Embase 中进行系统文献检索。这包括综述文章、随机对照试验、非随机临床试验(RCT)和病例系列。
有大量的介入性疼痛模式可用于肿瘤学疼痛管理。这些模式风险相对较低,能提供有效的镇痛,同时减少与阿片类药物使用障碍相关的问题。它们针对解剖和生理疼痛途径的各个区域,并为癌症和生存阶段的各个阶段提供更有针对性的疼痛管理选择。此外,随着无菌技术的提高、更好的成像方式以及技术和临床专业知识的不断增长,介入性疼痛模式如今提供了一种安全且通常更有效的疼痛管理方法。程序模式,如鞘内(IT)泵、神经调节、椎体后凸成形术和较新的更具针对性的消融技术,现在在癌症人群中越来越多地发现更多的作用和适应症。
介入性疼痛技术正在迅速发展,已成为癌症疼痛管理的重要组成部分。它们可以为癌症疼痛管理提供额外的选择,并有助于减少阿片类药物的消耗和相关的阿片类药物副作用。随着成像方式、程序技术、硬件和感染控制的改善,它们具有良好的安全性,并为癌症疼痛管理提供快速有效的方法。本文综述旨在提供对各种介入性疼痛模式的基本了解,包括其适应症、疗效、安全性数据和相关并发症。